Avience Biomedicals (NSE:AVIENCE) Other Stockholders Equity: ₹-0.0 Mil (As of Jan. 2026)


NSE:AVIENCE Avience Biomedicals Ltd NSE:AVIENCE
5 GF Score
Price ₹414.95
View Full Analysis

What is Avience Biomedicals Other Stockholders Equity?

Avience Biomedicals NSE:AVIENCE 5 Other Stockholders Equity is ₹-0.0 Mil as of Jan. 2026. GuruFocus rates NSE:AVIENCE with a GF Score™ of 5/100.

Avience Biomedicals's Other Stockholders Equity for the quarter that ended in Jan. 2026 was ₹-0.0 Mil.

Avience Biomedicals's quarterly Other Stockholders Equity declined from Mar. 2024 (₹0.0 Mil) to Mar. 2025 (₹-0.0 Mil) and declined from Mar. 2025 (₹-0.0 Mil) to Jan. 2026 (₹-0.0 Mil).

Avience Biomedicals's annual Other Stockholders Equity increased from Mar. 2023 (₹0.0 Mil) to Mar. 2024 (₹0.0 Mil) but then declined from Mar. 2024 (₹0.0 Mil) to Mar. 2025 (₹-0.0 Mil).

Avience Biomedicals Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Avience Biomedicals's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avience Biomedicals Other Stockholders Equity Chart

Avience Biomedicals Annual Data
Trend Mar23 Mar24 Mar25
Other Stockholders Equity
0.00 0.00 -0.00

Avience Biomedicals Quarterly Data
Mar23 Mar24 Mar25 Jan26
Other Stockholders Equity 0.00 0.00 -0.00 -0.00
NSE:AVIENCE
5GF Score
Avience Biomedicals Ltd NSE:AVIENCE
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Avience Biomedicals Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of ₹-0.0 Mil mean?
Avience Biomedicals (NSE:AVIENCE) has a Other Stockholders Equity of ₹-0.0 Mil as of Jan. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Avience Biomedicals and its competitors.
Is Avience Biomedicals' Other Stockholders Equity too high?
Avience Biomedicals' current Other Stockholders Equity is ₹-0.0 Mil. Overall, Avience Biomedicals has a GF Score™ of 5/100, reflecting its overall financial health beyond just this single metric.
How does Avience Biomedicals' Other Stockholders Equity compare to ABT and SYK?
Avience Biomedicals' Other Stockholders Equity of ₹-0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Devices & Instruments company?
A good Other Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Avience Biomedicals and its competitors. Avience Biomedicals's current Other Stockholders Equity is ₹-0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avience Biomedicals stock overvalued right now?
Avience Biomedicals (NSE:AVIENCE) has a current Other Stockholders Equity of ₹-0.0 Mil. The current Other Stockholders Equity is ₹-0.0 Mil. Avience Biomedicals' overall GF Score™ is 5/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Avience Biomedicals (NSE:AVIENCE), the current Other Stockholders Equity is ₹-0.0 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Avience Biomedicals Business Description

Address C-11, Block-C, Community Centre, Unit No-2, 1st Floor, Janakpuri A-3, New Delhi, IND, 110058
Avience Biomedicals Ltd is a medical consumables company focused on the manufacturing of Vitro-Diagnostic (IVD) products and medical devices. Its product offerings include diagnostic solutions used for the detection of diseases, conditions, and infections across laboratory, healthcare, and home-use applications. The company operates in areas including molecular biotechnology, genomics, and diagnostic products, and also provides distribution services for medical technology products in India. Its revenue is generated from Manufactured Goods and Traded Goods and Services, which include the sale of Medical Devices and Consumables.
5GF Score

Get the complete analysis for NSE:AVIENCE

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹414.95
Price